Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(13/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(13/week)
News
United States
(421/week)
Manufacturing
(319/week)
Technology
(320/week)
Energy
(213/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Rifaximin
May 06, 2020
Bausch Health And Alfasigma Announce Resolution Of XIFAXAN® Intellectual Property Litigation
Mar 31, 2020
Bausch Health Announces Favorable Topline Results From Study Evaluating Investigative Formulation of Rifaximin SSD IR to Treat Overt Hepatic Encephalopathy
Mar 09, 2020
The irritable bowel syndrome treatment market was valued at $1,071 million in 2018, and is estimated to reach at $2,012 million by 2026, registering a CAGR of 8.2% from 2019 to 2026
Feb 17, 2020
Irritable Bowel Syndrome Treatment Market to Reach $2.01 Bn, Globally, by 2026 at 8.2% CAGR, Says Allied Market Research
Oct 31, 2019
Salix Announces Issuance of an Additional XIFAXAN® Patent
Aug 12, 2019
First Patient Enrolled in Mallinckrodt's Phase 2a Study of Investigational Drug MNK-6106 in Hepatic Cirrhosis and Chronic Hepatic Encephalopathy (HE)
May 14, 2019
Salix Pharmaceuticals Marks 30-Year Anniversary With Largest Showing Of Data At Digestive Disease Week
Apr 25, 2019
Global $385 Mn Traveler's Diarrhea Markets, 2019-2028
Mar 27, 2019
Traveler's Diarrhea Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight
Dec 12, 2018
Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceuticals Inc.
Dec 06, 2018
ZAXINE® (rifaximin) - Now Indicated in Canada for Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D)1,2
Nov 16, 2018
FDA approves new drug to treat travelers' diarrhea
Oct 29, 2018
Salix And Alfasigma Will Initiate Late-Stage Program To Study Rifaximin In Patients With Postoperative Crohn's Disease
Oct 08, 2018
Salix to Present Clinical Data for XIFAXAN® (RIFAXIMIN) and PLENVU® at the American College of Gastroenterology Annual Meeting
Sep 12, 2018
Bausch Health Announces Resolution Of XIFAXAN® Intellectual Property Litigation
Jun 03, 2018
Salix Presents Positive Phase 3 Investigational Study Data For Repeat Rifaximin Treatment In Patients With Diarrhea Predominant Irritable Bowel Syndrome
Jun 03, 2018
Salix Presents Rifaximin Phase 3 Study Results for Irritable Bowel Syndrome with Diarrhea at Digestive Disease Week
May 31, 2018
Salix To Highlight New Clinical Data During Digestive Disease Week
Latest News
Mar 28, 2024
Yamaha Motor Signs Technical Partnership with Lola Cars for Development and Supply of Powertrains for Formula...
Mar 28, 2024
Black & Veatch Distributed Infrastructure Business Awarded Highest OSHA Star Recognition
Mar 28, 2024
ComPsych Corporation Announces 2023 Health at Work Award Winners
Mar 28, 2024
Boston Children’s Hospital and NRG Energy celebrate $1 million milestone, thanks to the Choose to Give program
Mar 28, 2024
Nordson EFD Releases New 3-Axis Automated Fluid Dispensing Systems
Mar 28, 2024
Green Boom Expands Product Line to The Home Depot
Mar 28, 2024
Space Executive Clay Mowry Joins Vast as Advisor
Mar 28, 2024
Thailand Construction Equipment Rental Market Assessment & Forecasts 2023-2024 and 2029: Increased Focus...
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events